Compare Cassava Sciences Inc (FLNA) vs Infosys Limited (INFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Infosys Limited — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Infosys Limited trades at $12.4 (market cap $50.55B). The key difference: Infosys Limited is far larger — about 1058.6× Cassava Sciences Inc's market cap, and Infosys Limited pays a 4.16% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | INFY | |
|---|---|---|
Market Cap | $47.75M | $50.55B |
Sector | Health | Technology |
52-Week High | $4.64 | $20.22 |
52-Week Low | $0.87 | $10.49 |
Enterprise Value | -$34.93M | $48.30B |
Dividend Yield | — | 4.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
